Results 91 to 100 of about 131,629 (255)

Resistance mechanisms and clonal dynamics in mantle cell lymphoma treated with sequential BTKi and venetoclax therapy

open access: yesThe Journal of Pathology, EarlyView.
Abstract In recent years, targeted therapies have become the standard of care for refractory/relapsed mantle cell lymphoma (MCL). Although the mutational profile of MCL has been extensively studied, there is a lack of understanding of resistance mechanisms and genetic factors that impact the response to novel treatments.
Tamás László   +19 more
wiley   +1 more source

Food Safety Practices and Foodborne Illness in Italian Pediatric Oncology and Hematology Centers: A Survey on Behalf of the Infectious Disease Working Group of AIEOP

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Food safety practices are widely recommended for pediatric patients with cancer or undergoing hematopoietic stem cell transplantation (HCT) to mitigate foodborne infectious risks. However, specific measures, such as the neutropenic diet (ND) or low‐microbial diet, lack robust evidence and are inconsistently implemented across ...
Davide Leardini   +28 more
wiley   +1 more source

Prediction of B/T Subtype and ETV6–RUNX1 Translocation in Pediatric Acute Lymphoblastic Leukemia by Deep Learning Analysis of Giemsa‐Stained Whole Slide Images of Bone Marrow Aspirates

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Accurate determination of B/T‐cell lineage and the presence of the ETV6–RUNX1 translocation is critical for diagnosing acute lymphoblastic leukemia (ALL), as these factors influence treatment decisions and outcomes. However, these diagnostic processes often rely on advanced tools unavailable in low‐resource settings, creating a need
Arkadi Piven   +6 more
wiley   +1 more source

Granulomatous Lymphangitis Masquerading as Relapsed Hodgkin Disease on FDG PET/CT. [PDF]

open access: yesTomography, 2018
Mustafa M   +4 more
europepmc   +1 more source

HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma [PDF]

open access: yes, 2017
Bianchi, Maurizio   +18 more
core   +1 more source

How I Approach Ethical Considerations for Pediatric Phase I CAR T‐Cell Trials

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Phase I trials of chimeric antigen receptor (CAR) T cells have shown remarkable promise in pediatric B‐cell malignancies. Such outcomes have shifted expectations for other phase I CAR T‐cell trials to have high response rates. The juxtaposition of high expectations, uncertain outcomes, and potential for life‐threatening toxicities raises ...
Sarah W. Peters   +6 more
wiley   +1 more source

Treatment‐Related Risk Factors for Diabetes Mellitus in Childhood Cancer Survivors—A Case‐Cohort Study Within Adult Life After Childhood Cancer in Scandinavia (ALiCCS)

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT The aim was to identify treatment‐related risk factors for diabetes in 5‐year survivors of childhood cancer (CCS). This case‐cohort study within Adult Life after Childhood Cancer in Scandinavia (ALiCCS) included 140 CCS with diabetes and a subcohort of 390 randomly selected CCS.
Line Kenborg   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy